PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$360.76
-9.40 (-2.54%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+12.57%
1Y
+702.58%
YTD
+25.96%
Open$372.26
Previous Close$370.16
Day High$381.98
Day Low$347.87
52W High$382.54
52W Low$37.19
Volume—
Avg Volume468.3K
Market Cap10.06B
P/E Ratio—
EPS$-13.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$296.27
Above
SMA 200
$133.67
Above
RSI (14)
61.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
-94.6% upside
Current
$360.76
$360.76
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |